Saturday, June 10, 2023
Disclosure of Conflicts of Interest
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclaimer This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Medical Director, SKiN Centre for Dermatology
Assistant Professor, Department of Medicine
Queen’s University
Kingston, Ontario, Canada
Consultant Physician
Peterborough Regional Health Centre
Peterborough, Ontario, Canada
Associate Professor of Dermatology
Yale University School of Medicine
New Haven, Connecticut, United States
President and Director of Research
Probity Medical Research
Waterloo, Ontario, Canada
Dorothy Caputo, MA, BSN, RN - AKH CE Director of Accreditations, has nothing to disclose.
Dorothy A. Duffy, RPh - AKH Pharmacy Reviewer, has nothing to disclose
AKH Planners and Reviewers have disclosed no relevant financial relationships.
AKH and LivDerm Planners and Reviewers have disclosed no relevant financial relationships. The content manager, Amy Kousouros, from LivDerm, has disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
This activity is designed for an audience of US-based dermatologists and allergists, physician assistants, pharmacists, and nurses who are involved in the care and treatment of patients with moderate to severe atopic dermatitis (AD).
The goal of this educational activity is to provide expert guidance to clinical learners on managing patients with AD.
Upon completion of this activity, participants will:
Disclosure of Conflicts of Interest
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.
Disclaimer This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Medical Director, SKiN Centre for Dermatology
Assistant Professor, Department of Medicine
Queen’s University
Kingston, Ontario, Canada
Consultant Physician
Peterborough Regional Health Centre
Peterborough, Ontario, Canada
Associate Professor of Dermatology
Yale University School of Medicine
New Haven, Connecticut, United States
President and Director of Research
Probity Medical Research
Waterloo, Ontario, Canada
Dorothy Caputo, MA, BSN, RN - AKH CE Director of Accreditations, has nothing to disclose.
Dorothy A. Duffy, RPh - AKH Pharmacy Reviewer, has nothing to disclose
AKH Planners and Reviewers have disclosed no relevant financial relationships.
AKH and LivDerm Planners and Reviewers have disclosed no relevant financial relationships. The content manager, Amy Kousouros, from LivDerm, has disclosed no relevant financial relationships.
All of the relevant financial relationships listed for these individuals have been mitigated.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring material activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
1.25 contact hours (0.0 contact hours are in the area of pharmacology)
AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 1.25 contact hour(s) (1.25 CEUs)
AKH In., Advancing Knowledge in Healthcare has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until 02/28/2023. PAs should only claim credit commensurate with the extent of their participation.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 3/11/2022
Valid for credit through: 3/11/2023
processing....
Before you begin, please answer the questions in this brief questionnaire.
